시장보고서
상품코드
1490041

골다공증 치료 시장 : 약물 종류별, 투여 경로별, 유통 채널별, 지역별

Osteoporosis Treatment Market, By Drug Type, By Route of Administration, By Distribution Channel, By Geography

발행일: | 리서치사: Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 골다공증 치료 시장은 2024년 149억 1,000만 달러로 추정되며, 2024년부터 2031년까지 CAGR 4.2%로 2031년에는 198억 4,000만 달러에 달할 것으로 예상됩니다.

보고서 범위 보고서 상세
기준 연도 2023 2024년 시장 규모 149억 1,000만 달러
실적 데이터 2019-2023년 예측 기간 2024-2031년
예측 기간 2024-2031년 CAGR: 4.20% 2031년 가치 예측 198억 4,000만 달러
그림. 골다공증 치료 시장 점유율(%), 지역별, 2024년
Osteoporosis Treatment Market-IMG1

골다공증은 골량 감소와 뼈 조직의 구조적 저하를 특징으로 하는 질환으로, 뼈가 약해지고 골절 위험이 높아지는 질환입니다. 골다공증은 특히 노인들 사이에서 전 세계 의료계의 큰 관심사가 되고 있습니다. 평균 수명의 증가, 좌식 생활습관, 부적절한 영양 섭취 등의 요인이 선진국과 개발도상국을 막론하고 골다공증 유병률 증가에 크게 기여하고 있으며, Frontiers 저널에 따르면 전 세계적으로 2억 명 이상이 골다공증으로 고통받고 있다고 합니다. 현재 치료법이 없기 때문에 약물 치료를 통한 평생 관리가 골절의 치료와 예방에 중요한 역할을 하고 있습니다. 세계 골다공증 치료 시장은 이러한 미충족 수요를 충족시키기 위해 지난 수십 년 동안 꾸준히 성장해 왔습니다.

시장 역학:

골다공증 위험이 높은 노인 인구의 증가는 전 세계적으로 골다공증 치료에 대한 수요를 증가시킬 것으로 예상됩니다. 유엔에 따르면, 65세 이상 인구는 2050년까지 2배 이상 증가할 것으로 예상됩니다. 골다공증 검진 및 관리에 대한 인식 증가, 신제품 출시, 위험에 처한 환자의 진단 증가는 시장 성장을 더욱 촉진하고 있습니다. 그러나 블록버스터 의약품의 특허 만료와 제네릭 의약품에 대한 선호는 시장 성장을 계속 억제하고 있습니다. 반면, 신흥국에서는 의료 서비스 접근성이 향상됨에 따라 큰 비즈니스 기회가 잠복해 있습니다.

본 조사의 주요 특징

  • 이 보고서는 세계 골다공증 치료 시장을 상세히 분석하고 2023년을 기준 연도로 하여 예측 기간(2024-2031년)의 시장 규모와 연평균 성장률(CAGR%)을 제시합니다.
  • 또한 다양한 부문에 걸친 잠재적 수익 성장 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
  • 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 인사이트를 제공합니다.
  • 세계 골다공증 치료 시장의 주요 기업 개요을 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 실적, 전략 등의 파라미터를 기준으로 정리했습니다.
  • 주요 기업으로는 Teva Pharmaceutical Industries Ltd., DAIICHI SANKYO COMPANY, LIMITED, Amgen Inc., Dr. Reddy's Laboratories Ltd., Viatris Inc., Ligand Pharmaceuticals Incorporated, Eli Lilly and Company, Asahi Kasei Corporation, F. Hoffmann-La Roche Ltd, EffRx Pharmaceuticals SA, Novartis AG, Merck & Co., Inc., GSK plc., Pfizer Inc., Enzene Biosciences, Apotex Inc. 등이 있습니다.
  • 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
  • 세계 골다공증 치료 시장은 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
  • 이해관계자들은 세계 골다공증 치료 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 조사 목적과 가정

  • 조사 목적
  • 가정
  • 약어

제2장 시장 전망

  • 보고서 설명
    • 시장 정의와 범위
  • 주요 요약
  • Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 기회
  • 영향 분석
  • 시장 동향
  • 주요 발전
  • 규제 시나리오
  • 제조업체 매출
  • 인수와 제휴 시나리오
  • 제품 발매/승인
  • 자금 조달과 투자
  • PEST 분석
  • Porters 분석

제4장 세계의 골다공증 치료 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

  • 전체적인 영향
  • 정부 이니셔티브
  • COVID-19의 시장에 대한 영향

제5장 세계의 골다공증 치료 시장, 약물 유형별, 2019-2031년

  • 비스포스포네이트
  • 칼시토닌, 호르몬요법
  • 선택적 에스트로겐 수용체 모듈레이터(SERM)
  • 부갑상선호르몬 관련 단백질(PTHrP) 유사체
  • 기타

제6장 세계의 골다공증 치료 시장, 투여 경로별, 2019-2031년

  • 경구
  • 주사
  • 기타

제7장 세계의 골다공증 치료 시장, 유통 채널별, 2019-2031년

  • 병원 약국
  • 소매 약국
  • 온라인 약국

제8장 세계의 골다공증 치료 시장, 지역별, 2019-2031년,

제9장 경쟁 상황

  • 기업 개요
    • Teva Pharmaceutical Industries Ltd.
    • DAIICHI SANKYO COMPANY, LIMITED
    • Amgen Inc.
    • Dr. Reddy's Laboratories Ltd.
    • Viatris Inc.
    • Ligand Pharmaceuticals Incorporated
    • Eli Lilly and Company
    • Asahi Kasei Corporation
    • F. Hoffmann-La Roche Ltd
    • EffRx Pharmaceuticals SA
    • Novartis AG
    • Merck &Co., Inc.
    • GSK plc.
    • Pfizer Inc.
    • Enzene Biosciences
    • Apotex Inc.

제10장 애널리스트의 제안

  • Wheel of Fortune
  • 애널리스트의 견해
  • Coherent Opportunity Map

제11장 참고문헌과 조사 방법

  • 참고문헌
  • 조사 방법
ksm 24.06.12

Global osteoporosis treatment market is estimated to be valued at USD 14.91 Bn in 2024 and is expected to reach USD 19.84 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 14.91 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 4.20% 2031 Value Projection: US$ 19.84 Bn
Figure. Osteoporosis Treatment Market Share (%), By Region, 2024
Osteoporosis Treatment Market - IMG1

Osteoporosis is a condition characterized by low bone mass and structural deterioration of bone tissue, leading to bone fragility and an increased risk of fractures. The disease has become a major global healthcare concern, especially among the elderly population. Factors such as increasing life expectancy, sedentary lifestyles, and improper nutrition have contributed significantly to rising prevalence of osteoporosis across both developed and developing nations. According to data published by Frontiers, over 200 million people worldwide suffer from osteoporosis. With no curative treatment currently available, lifelong management through pharmacotherapy plays a crucial role in treatment and prevention of fractures. Global osteoporosis treatment market has witnessed steady growth over the past couple of decades to meet this unmet need.

Market Dynamics:

Growing geriatric population who are at high risk of osteoporosis is expected to boost demand for osteoporosis treatment drugs globally. According to the United Nations, the population aged 65 years and above is expected to more than double by 2050. Rising awareness about osteoporosis screening and management, new product launches, and increasing at-risk patient diagnosis are further propelling the market growth. However, patent expiries of blockbuster drugs and preference for generic drugs continue to restrain the market growth. Meanwhile, significant opportunities lie in emerging economies due to growing accessibility of healthcare.

Key Features of the Study:

  • This report provides an in-depth analysis of the global osteoporosis treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global osteoporosis treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this includes Teva Pharmaceutical Industries Ltd., DAIICHI SANKYO COMPANY, LIMITED, Amgen Inc., Dr. Reddy's Laboratories Ltd., Viatris Inc., Ligand Pharmaceuticals Incorporated, Eli Lilly and Company, Asahi Kasei Corporation, F. Hoffmann-La Roche Ltd, EffRx Pharmaceuticals SA, Novartis AG, Merck & Co., Inc., GSK plc., Pfizer Inc., Enzene Biosciences, Apotex Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global osteoporosis treatment market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global osteoporosis treatment market.

Detailed Segmentation-

  • By Drug Type:
    • Bisphosphonates
    • Calcitonin, Hormone Therapy
    • Selective Estrogen Receptor Modulators (SERMs)
    • Parathyroid Hormone-Related Protein (PTHrP) Analog
    • Others
  • By Route of Administration:
    • Oral
    • Injectable
    • Others
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Teva Pharmaceutical Industries Ltd.
    • DAIICHI SANKYO COMPANY, LIMITED
    • Amgen Inc.
    • Reddy's Laboratories Ltd.
    • Viatris Inc.
    • Ligand Pharmaceuticals Incorporated
    • Eli Lilly and Company
    • Asahi Kasei Corporation
    • Hoffmann-La Roche Ltd
    • EffRx Pharmaceuticals SA
    • Novartis AG
    • Merck & Co., Inc.
    • GSK plc.
    • Pfizer Inc.
    • Enzene Biosciences
    • Apotex Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Drug Type
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Manufacturer Revenue
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Osteoporosis Treatment Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Osteoporosis Treatment Market, By Drug Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Bisphosphonates
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Calcitonin, Hormone Therapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Selective Estrogen Receptor Modulators (SERMs)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Parathyroid Hormone-Related Protein (PTHrP) Analog
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Osteoporosis Treatment Market, By Route of Administration, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Oral
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Injectable
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Osteoporosis Treatment Market, By Distribution Channel, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Hospital Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Retail Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Online Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Osteoporosis Treatment Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
      • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
      • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
      • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
      • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Teva Pharmaceutical Industries Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • DAIICHI SANKYO COMPANY, LIMITED
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Amgen Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Dr. Reddy's Laboratories Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Viatris Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Ligand Pharmaceuticals Incorporated
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Eli Lilly and Company
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Asahi Kasei Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • F. Hoffmann-La Roche Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • EffRx Pharmaceuticals SA
    • Novartis AG
    • Merck & Co., Inc.
    • GSK plc.
    • Pfizer Inc.
    • Enzene Biosciences
    • Apotex Inc.

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제